Vanderbilt-Ingram Cancer Center Archive — Page 22 of 28

Vanderbilt-Ingram website >

Head-and-shoulders portrait of a smiling man wearing glasses, a dark suit, light shirt, and patterned tie.
April 21, 2021

Zheng named VICC associate director for Population Sciences Research

Wei Zheng, MD, PhD, MPH, Anne Potter Wilson Professor of Medicine, has been named associate director for Population Sciences Research at Vanderbilt- Ingram Cancer Center (VICC).

By Tom Wilemon
Benjamin Brown, left, Jens Meiler, PhD, Zhenfang Du, PhD, and colleagues are studying the functional consequences of genetic mutations and how those changes can drive cancerous growth.
April 8, 2021

Personalized Structural Biology aids cancer treatment decisions

Cancer specialists at Vanderbilt University Medical Center, in partnership with biochemists and structural biologists across the Vanderbilt University campus, are taking “personalized” cancer therapy to a new level.

By Bill Snyder
VUMC NEWS logo in white lettering inside a cyan and yellow outlined square on a blue gradient background.
March 25, 2021

Forty-three percent of melanoma patients have chronic complications from immunotherapies

Chronic side effects among melanoma survivors after treatment with anti-PD-1 immunotherapies are more common than previously recognized, according to a study published March 25 in JAMA Oncology.

By Tom Wilemon
Dirty glass ashtray filled with cigarette butts and ash, with a lit cigarette resting across its rim on a white background.
March 9, 2021

Study incorporates genetics with smoking history to identify high-risk smokers for lung cancer screening

A study by Vanderbilt researchers that analyzed both smoking history and genetic risk variants for lung cancer supports modifying current guidelines to include additional smokers for lung cancer screening.

By Tom Wilemon
Three masked researchers stand in a laboratory between workstations, equipment, and shelves of bottles and supplies.
December 22, 2020

Arthritis drug may treat immunotherapy-related heart complication

By Tom Wilemon
Portrait of Cathy Eng, MD, wearing a white medical coat over a pink patterned blouse.
November 18, 2020

New drug for metastatic colorectal cancer enters phase 3 trial

A new therapy for metastatic colorectal cancer that has been granted fast track designation by the U.S. Food and Drug Administration is being tested in a phase 3 clinical trial at Vanderbilt-Ingram Cancer Center.

By Tom Wilemon